The Breathomics Profile of Volatile Sulfur Compounds in the Bipolar Spectrum, Does It Represent a Potential Tool for Early Diagnosis?
Journal of Clinical Medicine · 17.03.2025 · 14 (6) · 2025
DOI: 10.3390/jcm14062025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.03.2025. Verfasst von Federica Sancassiani und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences and Public Health, University of Cagliari, Monserrato Blocco I (CA), 09042 Cagliari, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione per la Tutela dell'Identità Ogliastrina e della Barbagia di Seulo, Fondazione per la Tutela dell’Identità Ogliastrina e della Barbagia di Seulo.
Abstract (Originalsprache)
Background/Objectives: Emerging laboratory technologies, such as breathomics, may enhance the early diagnosis of psychiatric disorders, including Bipolar Disorder (BD). This study investigates the detection of volatile sulfur compounds (VSCs) in exhaled breath as potential biomarkers for BD, comparing VSC levels between individuals with BD, healthy controls, and individuals with non-pathological hyperactivity.
Methods
A matched case–control study was conducted involving 24 patients with BD and 95 healthy controls recruited at the University Hospital of Cagliari. Controls were selected using a matched-pair design based on age (±5 years) and sex through a block-matching technique to ensure comparability with cases. Participants underwent psychiatric interviews, completed the Mood Disorder Questionnaire (MDQ), and had their exhaled breaths analyzed for VSCs using a gas chromatograph (OralChroma™). Controls were selected and randomized for age and sex.
Results
Patients with BD exhibited significantly higher levels of methyl mercaptan (CH3SH) compared to healthy controls (18.62 ± 5.04 vs. 9.45 ± 18.64 ppb, p = 0.022). Among individuals without BD, those with positive MDQ scores showed lower levels of CH3SH than those with negative scores (9.17 ± 5.42 vs. 15.05 ± 18.03); however, this difference did not reach statistical significance (p = 0.254), highlighting how the deep connection between some clinical and laboratory aspects needs to be investigated more thoroughly.
Conclusions
The results suggest a correlation between oral dysbiosis and metabolic alterations in patients with BD, with CH3SH levels being higher in cases compared to controls. Further studies are needed to validate the use of VSCs as potential biomarkers for BD and to investigate their role in individuals with non-pathological hyperactivity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences and Public Health, University of Cagliari, Monserrato Blocco I (CA), 09042 Cagliari, Italy.
- PhD Program in Tropical Medicine, Universidad Popular del Cesar, Valledupar 200001, Colombia.
- Department of Nursing, Universidad Popular del Cesar, Valledupar 200001, Colombia.
- University Hospital of Cagliari, 09042 Cagliari, Italy.
- Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
- Department of Surgical Sciences, University of Cagliari, Cittadella Universitaria, 09042 Cagliari, Italy.
ORCID-Profile: Federica Sancassiani, Mauro Giovanni Carta, Diego Primavera, Massimo Tusconi, Laura Atzori, Caterina Ferreli, Elisa Cantone, Goce Kalcev, Germano Orrù, Serdar M Dursun, Pedro José Fragoso Castilla, Shellsyn Giraldo Jaramillo, Giulia Cossu, Alessandra Scano
Förderung
- Fondazione per la Tutela dell'Identità Ogliastrina e della Barbagia di Seulo
- Fondazione per la Tutela dell’Identità Ogliastrina e della Barbagia di Seulo
Zitieren
APA
Sancassiani, F., Carta, M. G., Primavera, D., Tusconi, M., Urban, A., Atzori, L., Ferreli, C., Cantone, E., Cuccu, G. V., Kalcev, G., Orrù, G., Cabitza, F., Dursun, S. M., Aviles Gonzalez, C. I., Fragoso Castilla, P. J., Giraldo Jaramillo, S., Cossu, G., & Scano, A. (2025). The Breathomics Profile of Volatile Sulfur Compounds in the Bipolar Spectrum, Does It Represent a Potential Tool for Early Diagnosis?. Journal of Clinical Medicine, 14(6), 2025. https://doi.org/10.3390/jcm14062025
Vancouver
Sancassiani F, Carta MG, Primavera D, Tusconi M, Urban A, Atzori L, et al. The Breathomics Profile of Volatile Sulfur Compounds in the Bipolar Spectrum, Does It Represent a Potential Tool for Early Diagnosis?. Journal of Clinical Medicine. 2025;14(6):2025. doi:10.3390/jcm14062025
BibTeX
@article{Sancassiani2025,
author = {Sancassiani, Federica and Carta, Mauro Giovanni and Primavera, Diego and Tusconi, Massimo and Urban, Antonio and Atzori, Laura and Ferreli, Caterina and Cantone, Elisa and Cuccu, Gloria Virginia and Kalcev, Goce and Orrù, Germano and Cabitza, Flavio and Dursun, Serdar M and Aviles Gonzalez, Cesar Ivan and Fragoso Castilla, Pedro José and Giraldo Jaramillo, Shellsyn and Cossu, Giulia and Scano, Alessandra},
title = {The Breathomics Profile of Volatile Sulfur Compounds in the Bipolar Spectrum, Does It Represent a Potential Tool for Early Diagnosis?},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {6},
pages = {2025},
doi = {10.3390/jcm14062025}
}
EUVIMED